LiDiaTM, will feature a range of tests with the common characteristic that they provide vital, clinically actionable information fast to the benefit of the patient.
View our recent poster submission on Rapid Diagnosis of Bloodstream Infections Through Identification of Pathogens and Resistance Markers Directly from Whole Human Blood at 1 CFU/ml
User-friendly and flexible solution
All that are needed to complete the LiDia test are: a cartridge into which the sample is introduced: an instrument (or array of instruments for greater throughput) and a control screen.
Thanks to DNAe's semiconductor genomic analysis technology, it combines powerful analytical capability and accurate results with speed and simplicity.
Three simple steps
Easy to operate providing 24/7 diagnostics
Results in 3 hours at the point of need
Highly sensitive and specific
View product images
LiDia’s life saving potential
The first LiDia diagnostic test will identify directly, without the need for culture, the microbial cause of bloodstream infection leading to sepsis. Fast and accurate identification of the infection can be a lifesaver. Our test achieves this in about three hours, compared to at least a day for current tests that rely on a prior positive blood culture.
More diagnostic tests are under development in our labs to support clinicians in making critical treatment decisions.
Bloodstream infection (BSI)
pathogen identification by direct sequencing
a 10ml blood VacutainerTM or Monovette® in a disposable cartridge
results in about
cartridge into LiDia
DNAe Group Holdings Ltd
Ugli Campus Block C
56 Wood Lane
DNA Electronics, Inc.
1891 Rutherford Road
Carlsbad, CA 92008
+1 (760) 444-9410
KEEP IN TOUCH